这是一篇来自已证抗体库的有关斑马鱼 col2a1a的综述,是根据17篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合col2a1a 抗体。
col2a1a 同义词: col2a1; coll2a1; fb38c06; fc10c01; wu:fb38c06; wu:fc10c01; collagen alpha-1(II) chain; collagen type II, alpha 1

Developmental Studies Hybridoma Bank
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 斑马鱼; 1:100; 图 2
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II6B3)被用于被用于免疫组化-石蜡切片在斑马鱼样品上浓度为1:100 (图 2). J Histochem Cytochem (2019) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 小鼠; 图 4a
Developmental Studies Hybridoma Bank col2a1a抗体(Hybridoma Bank, II-II6B3)被用于被用于免疫组化-石蜡切片在小鼠样品上 (图 4a). J Clin Invest (2017) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 人类; 图 3b
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II6B3)被用于被用于免疫组化-石蜡切片在人类样品上 (图 3b). J Cell Physiol (2017) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化; 人类; 图 6
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化在人类样品上 (图 6). Stem Cell Res Ther (2016) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化; 斑马鱼; 图 3r
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II6B3)被用于被用于免疫组化在斑马鱼样品上 (图 3r). Nature (2016) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 狗; 0.02 ug/ml; 图 7
  • 免疫组化-石蜡切片; 小鼠; 0.02 ug/ml; 图 2
  • 免疫组化-石蜡切片; 人类; 0.4 ug/ml; 图 7
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化-石蜡切片在狗样品上浓度为0.02 ug/ml (图 7), 被用于免疫组化-石蜡切片在小鼠样品上浓度为0.02 ug/ml (图 2) 和 被用于免疫组化-石蜡切片在人类样品上浓度为0.4 ug/ml (图 7). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 人类; 图 7
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化-石蜡切片在人类样品上 (图 7). Tissue Eng Part A (2015) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 人类; 图 4
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II/II6B3)被用于被用于免疫组化-石蜡切片在人类样品上 (图 4). Stem Cell Reports (2015) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫细胞化学; 人类; 1:200
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank , II-II6B3)被用于被用于免疫细胞化学在人类样品上浓度为1:200. Tissue Eng Part A (2015) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-冰冻切片; 人类; 1:20
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II6B3)被用于被用于免疫组化-冰冻切片在人类样品上浓度为1:20. Eur Cell Mater (2015) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化; 牛; 1:200
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化在牛样品上浓度为1:200. Osteoarthritis Cartilage (2015) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-冰冻切片; 人类; 1:200
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化-冰冻切片在人类样品上浓度为1:200. PLoS ONE (2014) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化; 人类; 1:40
  • 免疫印迹; 人类; 1:500
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II6B3)被用于被用于免疫组化在人类样品上浓度为1:40 和 被用于免疫印迹在人类样品上浓度为1:500. Eur Cell Mater (2014) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 人类
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化-石蜡切片在人类样品上. Cell Tissue Res (2014) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化; 人类; 1:200; 图 3s
Developmental Studies Hybridoma Bank col2a1a抗体(DSHB, II-II6B3)被用于被用于免疫组化在人类样品上浓度为1:200 (图 3s). Clin Exp Metastasis (2014) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 人类; 2 ug/mL
Developmental Studies Hybridoma Bank col2a1a抗体(Hybridoma Bank, II-II6B3)被用于被用于免疫组化-石蜡切片在人类样品上浓度为2 ug/mL. Arthritis Res Ther (2013) ncbi
小鼠 单克隆(II-II6B3)
  • 免疫组化-石蜡切片; 人类
Developmental Studies Hybridoma Bank col2a1a抗体(Developmental Studies Hybridoma Bank, II-II6B3)被用于被用于免疫组化-石蜡切片在人类样品上. Tissue Eng Part A (2013) ncbi
文章列表
  1. Schulz A, Brendler J, Blaschuk O, Landgraf K, Krueger M, Ricken A. Nonpathological Chondrogenic Features of Valve Interstitial Cells in Normal Adult Zebrafish. J Histochem Cytochem. 2019;:22155418824083 pubmed 出版商
  2. Bartolomeo R, Cinque L, De Leonibus C, Forrester A, Salzano A, Monfregola J, et al. mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy. J Clin Invest. 2017;127:3717-3729 pubmed 出版商
  3. Diaz Romero J, Kürsener S, Kohl S, Nesic D. S100B?+?A1 CELISA: A Novel Potency Assay and Screening Tool for Redifferentiation Stimuli of Human Articular Chondrocytes. J Cell Physiol. 2017;232:1559-1570 pubmed 出版商
  4. Anderson D, Markway B, Bond D, McCarthy H, Johnstone B. Responses to altered oxygen tension are distinct between human stem cells of high and low chondrogenic capacity. Stem Cell Res Ther. 2016;7:154 pubmed
  5. Masselink W, Cole N, Fényes F, Berger S, Sonntag C, Wood A, et al. A somitic contribution to the apical ectodermal ridge is essential for fin formation. Nature. 2016;535:542-6 pubmed
  6. Bach F, Zhang Y, Miranda Bedate A, Verdonschot L, Bergknut N, Creemers L, et al. Increased caveolin-1 in intervertebral disc degeneration facilitates repair. Arthritis Res Ther. 2016;18:59 pubmed 出版商
  7. Antunes J, Tsaryk R, Gonçalves R, Pereira C, Landes C, Brochhausen C, et al. Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells. Tissue Eng Part A. 2015;21:1869-85 pubmed 出版商
  8. Narcisi R, Cleary M, Brama P, Hoogduijn M, Tüysüz N, ten Berge D, et al. Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation. Stem Cell Reports. 2015;4:459-72 pubmed 出版商
  9. Schrobback K, Klein T, Woodfield T. The importance of connexin hemichannels during chondroprogenitor cell differentiation in hydrogel versus microtissue culture models. Tissue Eng Part A. 2015;21:1785-94 pubmed 出版商
  10. Bertolo A, Hafner S, Taddei A, Baur M, Pötzel T, Steffen F, et al. Injectable microcarriers as human mesenchymal stem cell support and their application for cartilage and degenerated intervertebral disc repair. Eur Cell Mater. 2015;29:70-80; discujssion 80-1 pubmed
  11. Neu C, Novak T, Gilliland K, Marshall P, Calve S. Optical clearing in collagen- and proteoglycan-rich osteochondral tissues. Osteoarthritis Cartilage. 2015;23:405-13 pubmed 出版商
  12. Levett P, Hutmacher D, Malda J, Klein T. Hyaluronic acid enhances the mechanical properties of tissue-engineered cartilage constructs. PLoS ONE. 2014;9:e113216 pubmed 出版商
  13. Capossela S, Schlafli P, Bertolo A, Janner T, Stadler B, Pötzel T, et al. Degenerated human intervertebral discs contain autoantibodies against extracellular matrix proteins. Eur Cell Mater. 2014;27:251-63; discussion 263 pubmed
  14. Pei M, Li J, Zhang Y, Liu G, Wei L, Zhang Y. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356:391-403 pubmed 出版商
  15. Hesami P, Holzapfel B, Taubenberger A, Roudier M, Fazli L, Sieh S, et al. A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone. Clin Exp Metastasis. 2014;31:435-46 pubmed 出版商
  16. Hasegawa A, Nakahara H, Kinoshita M, Asahara H, Koziol J, Lotz M. Cellular and extracellular matrix changes in anterior cruciate ligaments during human knee aging and osteoarthritis. Arthritis Res Ther. 2013;15:R29 pubmed 出版商
  17. Cheng N, Estes B, Young T, Guilak F. Genipin-crosslinked cartilage-derived matrix as a scaffold for human adipose-derived stem cell chondrogenesis. Tissue Eng Part A. 2013;19:484-96 pubmed 出版商